AI Robotics in Medicine
PublicTracking updates in AI Robotics in the healthcare industry
Cornerstone Robot Secures EU MDR, Singapore HSA; GE-UW Imaging Push
Monday, May 25, 2026
Advanced medtech is coalescing around evidence-backed automation: Cornerstone’s Sentire robot wins EU MDR and Singapore HSA clearances while GE HealthCare and UW Medicine expand CT and molecular imaging research to streamline workflows and accelerate clinical translation.
The tension is timing—Cornerstone is positioned for scaled rollout, backed by UK clinical experience, clinician satisfaction, and training, while GE-UW seeds the next wave with spectral imaging and automation; watch how evidence and enablement convert innovation into adoption across Europe and Asia-Pacific.
Tracking: Medicine Robotics · AI Medicine · AI Healthcare
Geography: United States, European Union, United Kingdom, Canada, Israel, China, Japan, South Korea, India, Singapore, Boston, San Francisco Bay Area, Seattle, London, Cambridge (UK), Berlin, Paris, Tel Aviv, Beijing, Shanghai, Shenzhen, Tokyo, Seoul, Bengaluru, Toronto, Washington, D.C., Brussels
1. Cornerstone’s Sentire Surgical Robot Wins EU MDR and Singapore HSA Clearances
Cornerstone Robotics’ Sentire Endoscopic Surgical System secured a CE mark under the EU Medical Device Regulation and, simultaneously, Singapore HSA certification.
The approvals cover minimally invasive procedures in general surgery, gynecology, thoracic, and urology, opening access to European and Asia-Pacific markets. Cornerstone, based in Hong Kong, announced the milestone on May 25, 2026.
Since 2025, the company has run a clinical investigation with Portsmouth Hospitals University NHS Trust, completing numerous complex procedures across urology, gynecology, and upper and lower gastrointestinal surgery.
Investigators reported that patient outcomes were achieved and clinicians were very satisfied with performance.
Cornerstone also set up a UK subsidiary in 2025, providing training, clinical technical support, and after-sales service, with multiple UK training sessions completed to prepare for scaled rollout.
Key facts:
- CE mark (MDR) announced May 25, 2026, for Sentire Surgical System.
- Simultaneous Singapore HSA certification for general surgery, gynecology, thoracic, and urology.
- UK clinical investigation with Portsmouth Hospitals University NHS Trust since 2025.
- Numerous complex UK procedures across urology, gynecology, upper and lower gastrointestinal surgery.
- UK subsidiary established in 2025; training, technical support, and after-sales service.
Why it matters: Dual certifications open immediate commercialization in Europe and Singapore, with local UK training, technical support, and after-sales services reducing adoption hurdles.
Real-world data from the PHU investigation—aligned to evidence-based research, training protocol development, and clinical adoption—can strengthen hospital evaluations.
Watch for the scale and speed of commercial rollout, additional training cohorts, and further clinical data disclosures in certified markets.
2. GE HealthCare, UW Medicine Radiology expand CT and molecular imaging research
GE HealthCare Technologies entered a research collaboration with the University of Washington’s Department of Radiology focused on advancing computed tomography and molecular imaging technologies.
The effort targets workflow automation across cardiology, oncology, and theranostics while accelerating clinical translation of next‑generation imaging.
Company leadership said CT and molecular imaging are converging to improve disease detection and characterization across the patient journey.
The partnership extends a 30‑year relationship and launches two core programs to speed imaging and workflow innovation.
The CT program will generate clinical evidence for spectral imaging and develop automation and software tools to boost efficiency and patient experience.
GE HealthCare frames the tie‑up as part of its strategy to pair AI and automation with imaging hardware to deliver more precise, actionable insights and support broader adoption globally.
Key facts:
- GE HealthCare and UW Medicine Radiology formed a CT and molecular imaging research collaboration.
- The partnership builds on a 30-year GE HealthCare–UW Medicine Radiology relationship.
- Two core programs include advancing CT spectral imaging and workflow automation.
- Shares fell 0.2% since the announcement on Thursday.
- GE HealthCare shares are down 21.7% year to date; industry down 22.2%.
Why it matters: Embedding development in a leading academic radiology department gives GE HealthCare real‑world settings to refine and validate next‑generation CT and molecular imaging tools.
If successful, clinical evidence for spectral imaging and automated workflows could accelerate adoption across health systems, improve clinician efficiency, and enhance patient experience.
The collaboration also reinforces GE HealthCare’s strategy to combine AI, automation, and imaging hardware to deliver more precise, personalized insights at scale.